Get startedLog in
    Picture of Hercules Capital logo

    HTGC — Hercules Capital News Story

    0.000.00%
    us flag iconLast trade - 00:00
    FinancialsConservativeMid CapNeutral
    All News

    Brief: X4 Pharmaceuticals Announces $125 Million Capital Infusion From $105 Million Sale Of Priority Review Voucher And $20 Million Drawdown From Existing Loan Facility

    Picture of Hercules Capital logoHercules Capital
    09/05/2024 12:47
    May 9 (Reuters) - Hercules Capital Inc  HTGC.N :
    * X4 PHARMACEUTICALS ANNOUNCES $125 MILLION CAPITAL INFUSION
FROM
$105 MILLION SALE OF PRIORITY REVIEW VOUCHER AND $20 MILLION
DRAWDOWN FROM EXISTING LOAN FACILITY
    * X4: $125 MILLION OF NON-DILUTIVE CAPITAL EXTENDS PROJECTED
CASH
RUNWAY INTO LATE 2025, EXCLUDING EXPECTED COMMERCIAL SALES FROM
XOLREMDI

Source text for Eikon:  ID:nGNX1Hk6PK 
Further company coverage:  HTGC.N 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Hercules Capital

    See all news